Revance(RVNC) - 2022 Q4 - Earnings Call Transcript

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2022 Earnings Conference Call February 28, 2023 4:30 AM ET Company Participants Jessica Serra – Head of Investor Relations and ESG Mark Foley – Chief Executive Officer Dustin Sjuts – President Toby Schilke – Chief Financial Officer Conference Call Participants David Amsellem – Piper Sandler Annabel Samimy – Stifel Seamus Fernandez – Guggenheim Securities Stacy Ku – Cowen Balaji Prasad – Barclays Lachlan Hanbury-Brown – William Blair Terence Flynn – Morgan Stanley ...